Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach-Reference-Cited by-同舟云学术

Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach

Published:2012-10-29 Issue:10 Volume:7 Page:e47655
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boyer Laurent,Cermolacce Michel,Dassa Daniel,Fernandez Jessica,Boucekine Mohamed,Richieri Raphaelle,Vaillant Florence,Dumas Remy,Auquier Pascal,Lancon Christophe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Choice of maintenance medication for schizophrenia;JM Davis;J Clin Psychiatry,2003

2. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder;D Robinson;Arch Gen Psychiatry,1999

3. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia;S Leucht;J Clin Psychiatry,2006

4. Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review;PS Masand;Prim Care Companion J Clin Psychiatry,2009

5. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness;DI Velligan;J Clin Psychiatry,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Combined Use of Beauveria bassiana (Balsamo) Vuillemin and Diatomaceous Earth for the Control of Tribolium castaneum (Herbst) and Trogoderma granarium Everts;Pakistan Journal of Zoology;2024

2. Can temporal self-regulation theory and its constructs predict medication adherence? A systematic review and meta-analysis;Health Psychology Review;2022-10-11

3. Relationships Between Multiple Dimensions of Insight and Neurocognition, Metacognition, and Social Cognition;Journal of Nervous & Mental Disease;2022-08

4. The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2019-03

5. Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia;Indian Journal of Psychiatry;2019